Conversely, in tumors with downregulated USP21, EGFR undergoes ubiquitination and subsequent degradation within MVB-lysosome vesicles, leading to reduced cancer progression due to diminished EGF engagement (Fig. 7C). The gene discussed is USP21; the disease is cancer.